Yüklüyor......
Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic...
Kaydedildi:
| Yayımlandı: | Trauma Surg Acute Care Open |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993337/ https://ncbi.nlm.nih.gov/pubmed/33880414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2021-000682 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|